PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY:
- 1 January 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Biological Determinants of Cancer Progression in Men With Prostate CancerJAMA, 1999
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Prospective Longitudinal Evaluation of Men With Initial Prostate Specific Antigen Levels of 4.0 Ng./Ml. or LessJournal of Urology, 1997
- Limitations of Serum Prostate Specific Antigen in Predicting Peripheral and Transition Zone Cancer Volumes as Measured by Correlation CoefficientsJournal of Urology, 1996
- Tumor Volume and Prostate Specific Antigen: Implications for Early Detection and Defining a Window of CurabilityJournal of Urology, 1995
- Prostate Specific Antigen and Gleason Grade: An Immunohistochemical Study of Prostate CancerJournal of Urology, 1994
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the ProstateAmerican Journal of Clinical Pathology, 1984